The immersive experience of virtual reality during chemotherapy in patients with early breast and ovarian cancers: The patient's dream study.

ABSTRACT:

Background

A virtual reality experience (VRE) could represent a viable non-pharmacological intervention to reduce and better manage the main factors of psychophysical distress related to the diagnosis and treatment of cancer.

Aim

The "Patient's Dream" study was a two-arm randomized controlled trial conducted at the Regina Elena National Cancer Institute - IRCCS (Rome, Italy) from April 2019 to January 2020 to evaluate VRE impact in patients affected by breast or ovarian cancer. Before starting the first cycle of chemotherapy (CT), patients were randomized to receive the VRE (VRE arm) as "distraction therapy" or to entertain themselves with conventional means (control arm). The primary aims were the assessment of psychological distress, anxiety and quality of life betw

SUBMITTER: Fabi A 

PROVIDER: S-EPMC9563848 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature